Effect of canagliflozin on white blood cell counts in patients with type 2 diabetes and heart failure: A subanalysis of the randomized CANDLE trial

AIMS/INTRODUCTION: Clinical evidence is lacking about the influence of sodium–glucose cotransporter 2 inhibitors on white blood cell (WBC) counts, a commonly used and widely available marker of inflammation. The aim of the present analysis was to assess the effect of canagliflozin relative to glimep...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Atsushi, Imai, Takumi, Shimabukuro, Michio, Nakamura, Ikuko, Matsunaga, Kazuo, Ozaki, Yukio, Minamino, Tohru, Sata, Masataka, Node, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720210/
https://www.ncbi.nlm.nih.gov/pubmed/36114704
http://dx.doi.org/10.1111/jdi.13899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720210/
https://www.ncbi.nlm.nih.gov/pubmed/36114704
http://dx.doi.org/10.1111/jdi.13899

Ejemplares similares